Bosutinib – Bosulif approved for Leukemia by Pfizer

A new anticancer drug for Leukemia has been approved by FDA. The drug treats chronic myelogenous leukemia (CML), a blood and bone marrow disease that usually affects seniors.

 

Bosutinib-Bosulif

It works by inhibiting the enzyme Tyrosine Kinase.

 

Enhanced by Zemanta

Incoming terms:

Leave a Reply

Your email address will not be published. Required fields are marked *